315 related articles for article (PubMed ID: 25053719)
21. Effects of HIV infection on maternal and neonatal health in southern Mozambique: A prospective cohort study after a decade of antiretroviral drugs roll out.
González R; Rupérez M; Sevene E; Vala A; Maculuve S; Bulo H; Nhacolo A; Mayor A; Aponte JJ; Macete E; Menendez C
PLoS One; 2017; 12(6):e0178134. PubMed ID: 28575010
[TBL] [Abstract][Full Text] [Related]
22. Maternal HIV infection and vertical transmission of pathogenic bacteria.
Cutland CL; Schrag SJ; Zell ER; Kuwanda L; Buchmann E; Velaphi SC; Groome MJ; Adrian PV; Madhi SA;
Pediatrics; 2012 Sep; 130(3):e581-90. PubMed ID: 22869824
[TBL] [Abstract][Full Text] [Related]
23. Reduction in perinatal transmission and mortality from human immunodeficiency virus after intervention with zidovudine in Barbados.
St John AM; Kumar A; Cave C
Pediatr Infect Dis J; 2003 May; 22(5):422-6. PubMed ID: 12792382
[TBL] [Abstract][Full Text] [Related]
24. Postpartum tuberculosis incidence and mortality among HIV-infected women and their infants in Pune, India, 2002-2005.
Gupta A; Nayak U; Ram M; Bhosale R; Patil S; Basavraj A; Kakrani A; Philip S; Desai D; Sastry J; Bollinger RC;
Clin Infect Dis; 2007 Jul; 45(2):241-9. PubMed ID: 17578786
[TBL] [Abstract][Full Text] [Related]
25. Antiretroviral therapy in pregnant women with advanced HIV disease and pregnancy outcomes in Abidjan, Côte d'Ivoire.
Ekouevi DK; Coffie PA; Becquet R; Tonwe-Gold B; Horo A; Thiebaut R; Leroy V; Blanche S; Dabis F; Abrams EJ
AIDS; 2008 Sep; 22(14):1815-20. PubMed ID: 18753864
[TBL] [Abstract][Full Text] [Related]
26. HIV infections in obstetrics and gynaecology.
Mola G
P N G Med J; 1996 Sep; 39(3):190-5. PubMed ID: 9795561
[TBL] [Abstract][Full Text] [Related]
27. Postnatal HIV-1 transmission after cessation of infant extended antiretroviral prophylaxis and effect of maternal highly active antiretroviral therapy.
Taha TE; Kumwenda J; Cole SR; Hoover DR; Kafulafula G; Fowler MG; Thigpen MC; Li Q; Kumwenda NI; Mofenson L
J Infect Dis; 2009 Nov; 200(10):1490-7. PubMed ID: 19832114
[TBL] [Abstract][Full Text] [Related]
28. Increased infant human immunodeficiency virus-type one free survival at one year of age in sub-saharan Africa with maternal use of highly active antiretroviral therapy during breast-feeding.
Marazzi MC; Nielsen-Saines K; Buonomo E; Scarcella P; Germano P; Majid NA; Zimba I; Ceffa S; Palombi L
Pediatr Infect Dis J; 2009 Jun; 28(6):483-7. PubMed ID: 19483516
[TBL] [Abstract][Full Text] [Related]
29. Factors associated with mother-to-child transmission of HIV-1 despite a maternal viral load <500 copies/ml at delivery: a case-control study nested in the French perinatal cohort (EPF-ANRS CO1).
Tubiana R; Le Chenadec J; Rouzioux C; Mandelbrot L; Hamrene K; Dollfus C; Faye A; Delaugerre C; Blanche S; Warszawski J
Clin Infect Dis; 2010 Feb; 50(4):585-96. PubMed ID: 20070234
[TBL] [Abstract][Full Text] [Related]
30. Neonatal predictors of infection status and early death among 332 infants at risk of HIV-1 infection monitored prospectively from birth. New York City Perinatal HIV Transmission Collaborative Study Group.
Abrams EJ; Matheson PB; Thomas PA; Thea DM; Krasinski K; Lambert G; Shaffer N; Bamji M; Hutson D; Grimm K
Pediatrics; 1995 Sep; 96(3 Pt 1):451-8. PubMed ID: 7651777
[TBL] [Abstract][Full Text] [Related]
31. Antiretroviral treatment and prevention of peripartum and postnatal HIV transmission in West Africa: evaluation of a two-tiered approach.
Tonwe-Gold B; Ekouevi DK; Viho I; Amani-Bosse C; Toure S; Coffie PA; Rouet F; Becquet R; Leroy V; El-Sadr WM; Abrams EJ; Dabis F
PLoS Med; 2007 Aug; 4(8):e257. PubMed ID: 17713983
[TBL] [Abstract][Full Text] [Related]
32. Twelve-month follow-up of Six Week Extended Dose Nevirapine randomized controlled trials: differential impact of extended-dose nevirapine on mother-to-child transmission and infant death by maternal CD4 cell count.
Omer SB;
AIDS; 2011 Mar; 25(6):767-76. PubMed ID: 21330912
[TBL] [Abstract][Full Text] [Related]
33. Evidence for extended age dependent maternal immunity in infected children: mother to child transmission of HIV infection and potential interventions including sulfatides of the human fetal adnexa and complementary or alternative medicines.
Bhargav H; Huilgol V; Metri K; Sundell IB; Tripathi S; Ramagouda N; Jadhav M; Raghuram N; Ramarao NH; Koka PS
J Stem Cells; 2012; 7(3):127-53. PubMed ID: 23619381
[TBL] [Abstract][Full Text] [Related]
34. Premature delivery in HIV-infected women starting protease inhibitor therapy during pregnancy: role of the ritonavir boost?
Sibiude J; Warszawski J; Tubiana R; Dollfus C; Faye A; Rouzioux C; Teglas JP; Ekoukou D; Blanche S; Mandelbrot L
Clin Infect Dis; 2012 May; 54(9):1348-60. PubMed ID: 22460969
[TBL] [Abstract][Full Text] [Related]
35. Pediatric AIDS and perinatal HIV infection in Zaire: epidemiologic and pathologic findings.
Nelson AM; Firpo A; Kamenga M; Davachi F; Angritt P; Mullick FG
Prog AIDS Pathol; 1992; 3(1):1-33. PubMed ID: 1606299
[TBL] [Abstract][Full Text] [Related]
36. Decreased risk of congenital cytomegalovirus infection in children born to HIV-1-infected mothers in the era of highly active antiretroviral therapy.
Guibert G; Warszawski J; Le Chenadec J; Blanche S; Benmebarek Y; Mandelbrot L; Tubiana R; Rouzioux C; Leruez-Ville M;
Clin Infect Dis; 2009 Jun; 48(11):1516-25. PubMed ID: 19388872
[TBL] [Abstract][Full Text] [Related]
37. Maternal levels of plasma human immunodeficiency virus type 1 RNA and the risk of perinatal transmission. Women and Infants Transmission Study Group.
Garcia PM; Kalish LA; Pitt J; Minkoff H; Quinn TC; Burchett SK; Kornegay J; Jackson B; Moye J; Hanson C; Zorrilla C; Lew JF
N Engl J Med; 1999 Aug; 341(6):394-402. PubMed ID: 10432324
[TBL] [Abstract][Full Text] [Related]
38. Influence of highly active antiretroviral treatment (HAART) on risk factors for vertical HIV transmission.
Garcia-Tejedor A; Maiques V; Perales A; Lopez-Aldeguer J
Acta Obstet Gynecol Scand; 2009; 88(8):882-7. PubMed ID: 19557554
[TBL] [Abstract][Full Text] [Related]
39. Does severity of HIV disease in HIV-infected mothers affect mortality and morbidity among their uninfected infants?
Kuhn L; Kasonde P; Sinkala M; Kankasa C; Semrau K; Scott N; Tsai WY; Vermund SH; Aldrovandi GM; Thea DM
Clin Infect Dis; 2005 Dec; 41(11):1654-61. PubMed ID: 16267740
[TBL] [Abstract][Full Text] [Related]
40. The Effect of Human Immunodeficiency Virus and Cytomegalovirus Infection on Infant Responses to Vaccines: A Review.
Falconer O; Newell ML; Jones CE
Front Immunol; 2018; 9():328. PubMed ID: 29552009
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
